Impax Labs Shifts 110 Drug-Production Jobs To Taiwan
This article was originally published in PharmAsia News
Executive Summary
A U.S. loss is Taiwan's gain as Impax Laboratories fired about 10% of its work force at home to shift production of its generic drugs to the Asian nation.